These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate. Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880 [TBL] [Abstract][Full Text] [Related]
24. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease. Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065 [TBL] [Abstract][Full Text] [Related]
25. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats. Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499 [TBL] [Abstract][Full Text] [Related]
26. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis. Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216 [TBL] [Abstract][Full Text] [Related]
27. Reductions in gut microbiota‑derived metabolite trimethylamine N‑oxide in the circulation may ameliorate myocardial infarction‑induced heart failure in rats, possibly by inhibiting interleukin‑8 secretion. Li X; Sun Y; Zhang X; Wang J Mol Med Rep; 2019 Jul; 20(1):779-786. PubMed ID: 31180562 [TBL] [Abstract][Full Text] [Related]
28. Suppression of trimethylamine N-oxide with DMB mitigates vascular dysfunction, exercise intolerance, and frailty associated with a Western-style diet in mice. Brunt VE; Greenberg NT; Sapinsley ZJ; Casso AG; Richey JJ; VanDongen NS; Gioscia-Ryan RA; Ziemba BP; Neilson AP; Davy KP; Seals DR J Appl Physiol (1985); 2022 Oct; 133(4):798-813. PubMed ID: 35952350 [TBL] [Abstract][Full Text] [Related]
29. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine Johnson C; Prokopienko AJ; West RE; Nolin TD; Stubbs JR Drug Metab Dispos; 2018 Sep; 46(9):1304-1309. PubMed ID: 29915157 [TBL] [Abstract][Full Text] [Related]
30. Long-chain acylcarnitine 18:1 acutely increases human atrial myocardial contractility and arrhythmia susceptibility. Aitken-Buck HM; Krause J; van Hout I; Davis PJ; Bunton RW; Parry DJ; Williams MJA; Coffey S; Zeller T; Jones PP; Lamberts RR Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H162-H174. PubMed ID: 34085842 [TBL] [Abstract][Full Text] [Related]
33. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity. Sun G; Yin Z; Liu N; Bian X; Yu R; Su X; Zhang B; Wang Y Biochem Biophys Res Commun; 2017 Nov; 493(2):964-970. PubMed ID: 28942145 [TBL] [Abstract][Full Text] [Related]
34. The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease. Pan S; Zhao D; Duan S; Chen X Int Urol Nephrol; 2023 Jul; 55(7):1747-1756. PubMed ID: 36797553 [TBL] [Abstract][Full Text] [Related]
35. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Kennedy RH; Owings R; Shekhawat N; Joseph J Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H812-7. PubMed ID: 15072957 [TBL] [Abstract][Full Text] [Related]
36. Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats. Huc T; Drapala A; Gawrys M; Konop M; Bielinska K; Zaorska E; Samborowska E; Wyczalkowska-Tomasik A; Pączek L; Dadlez M; Ufnal M Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1805-H1820. PubMed ID: 30265149 [TBL] [Abstract][Full Text] [Related]
37. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Weyrich AS; Ma XL; Buerke M; Murohara T; Armstead VE; Lefer AM; Nicolas JM; Thomas AP; Lefer DJ; Vinten-Johansen J Circ Res; 1994 Oct; 75(4):692-700. PubMed ID: 7923615 [TBL] [Abstract][Full Text] [Related]
38. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction. Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610 [TBL] [Abstract][Full Text] [Related]
39. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. Stubbs JR; House JA; Ocque AJ; Zhang S; Johnson C; Kimber C; Schmidt K; Gupta A; Wetmore JB; Nolin TD; Spertus JA; Yu AS J Am Soc Nephrol; 2016 Jan; 27(1):305-13. PubMed ID: 26229137 [TBL] [Abstract][Full Text] [Related]
40. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate. Ririe DG; Butterworth JF; Royster RL; MacGregor DA; Zaloga GP Anesthesiology; 1995 Apr; 82(4):1004-12. PubMed ID: 7717535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]